Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY
Amy Schulman exercised options for 11,250 Alnylam Pharmaceuticals, Inc. shares (Form 4)
Traded May 13, 2026 · Filed May 14, 2026
On May 13, 2026, Amy Schulman (Director) exercised options for 11,250 Alnylam Pharmaceuticals, Inc. shares at US$70.20 for US$790K, leaving 23,211 shares. Filed May 14, 2026 (Form 4).
- Options exercised
- 11,250 shares
- Price
- US$70.20
- Value
- US$790K
- Holding after
- 23,211 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | Option exercise | 11,250 | US$70.20 | 23,211 | Direct |
Source
Related
- Alnylam Pharmaceuticals, Inc.
- Amy Schulman
- Alnylam Pharmaceuticals, Inc. shareholders
- Form 4 · Amy Schulman · May 22, 2026
- Form 4 · Supran Bryan · Oct 6, 2026
- Form 4 · Greenstreet Yvonne · Sep 22, 2026
- Form 4 · Pyott David E I · Jun 3, 2026
- Form 4 · Sigal Charles Elliott · May 22, 2026
- Form 4 · Reitan Colleen F · May 22, 2026